All Posts > Content under Pharma/Biotech
Chart Of The Day - Athersys (ATHX)
Article By:
Jim Van Meerten
Read
Friday, January 10, 2014 9:46 AM EDT
ATHX it is a biopharmaceutical company engaged in the discovery/development of therapeutic product candidates designed to extend and enhance the quality of human life. Since the Trend Spotter signaled a buy on 12/17 the stock soared 194.69%.
In this article: ATHX
Chart Of The Day - Meridian Bioscience (VIVO)
Article By:
Jim Van Meerten
Read
Thursday, January 9, 2014 10:36 AM EDT
Meridian Bioscoence (VIVO) is a fully integrated life sciences company. Since the Trend Spotter signaled a buy on 12/13 the stock is up 7.85%.
In this article: VIVO
Market Commentary: Averages Melt Downward Marking New Lows For This Session
Article By:
Steven Hansen
Read
Thursday, January 9, 2014 10:20 AM EDT
Except from a brief pause this morning, the averages have continued to melt downward and are all in the red. The volume at noon-time is dipping into the anemic levels and the $VIX remains in the low 13's.
Mid Cap Report
Article By:
E.B. Capital Markets
Read
Thursday, January 9, 2014 6:00 AM EDT
The best scoring mid caps from one year ago (1/10/2013) averaged 551 bps of excess over the S&P 400, with 0% turnover. The top performers included NFLX up 270%, ILMN up 102%, ACXM up 96%, HBI up 94%, MAN up 92%, and GMCR up 91%.
Middle East Power Cooperation Brings Profits And Peace
Article By:
Vivian Lewis
Read
Tuesday, January 7, 2014 1:48 PM EDT
Israel's Delek Group & Palestine Power Generation Co sign a natural gas deal furthering both profits and peace. Also Jordan's Hikma Pharma - one of the best performers in dollars this week.
Weekly Investment Report: The Best And Worst In ADRs (INFY, PSDV, ARMH, MPEL)
Article By:
E.B. Capital Markets
Read
Monday, January 6, 2014 4:09 PM EDT
The best scoring ADRs from one year ago returned 43.67% this past year, 23.44% more than the MSCI EAFE, with 0% turnover. The top performers from our list 1 year ago include HIMX, GENT, CTRP, MPEL, and GA.
Insider Trading Report: The Week's Notable Insider Buys And Sales
Article By:
Asif Suria
Read
Monday, January 6, 2014 2:38 PM EDT
Notable Insider Buys: Opko Health, BioTime, Wheeler Real Estate Investment Trust, SP Plus Corp., and CEL-SCI.
Notable Insider Sales: Monster Beverage Corp., Fidelity National Financial, FleetCor Technologies, Kodiak Oil & Gas Corp., and Groupon.
Added A New Equity Buy, Sold Some LEAP Puts
Article By:
Dr. Paul Price
Read
Monday, January 6, 2014 12:13 PM EDT
These shares trade for just 8 times trailing earnigns and yield 3.27%.
Selling long-term puts brings our break-even price down to 2008's price point.
In this article: TEVA
$500 Billion In 2013 Corporate Buybacks: Half Of QE
Article By:
Tyler Durden
Read
Monday, January 6, 2014 10:16 AM EDT
What may not be known is just how large the total amount of corporate buybacks in the past year was. The answer: the second highest in history, just shy record of 2007 amounting to $500 billion.
Shakeup At Teva Pharmaceutical And Other Global Updates
Article By:
Vivian Lewis
Read
Saturday, January 4, 2014 12:00 PM EDT
Possible shakeup at Teva while Jazz Pharma to acquire Gentium. Plus more news on Hikma Pharmaceuticals, Bombardier, Ituran, Tencent Holdings, Nokia, Covidien, and Mongolia Growth Group.
2014's Trade Of The Year?
Article By:
Dr. Paul Price
Read
Friday, January 3, 2014 10:08 PM EDT
The best asset class for the year ahead might prove to be a surprise.
In this article: EMF
BEA Revises 3rd Quarter 2013 GDP Growth Upward Again
Article By:
Rick Davis
Read
Friday, January 3, 2014 4:44 PM EDT
In their third and final estimate of the US GDP for the third quarter of 2013, the Bureau of Economic Analysis (BEA) reported that the economy was growing at a 4.12% annualized rate, up another 0.52% from the 3.60% growth rate previously reported for the third quarter.